TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327,750 | -48.7% | 25,000 | 0.0% | 0.03% | -56.6% |
| Q2 2023 | $639,500 | +1.5% | 25,000 | 0.0% | 0.08% | -49.7% |
| Q1 2023 | $629,750 | +55.9% | 25,000 | +66.7% | 0.15% | +906.7% |
| Q3 2021 | $404,000 | -91.4% | 15,000 | -90.0% | 0.02% | -91.6% |
| Q2 2021 | $4,689,000 | – | 150,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT CENTURY GROWTH INVESTORS LLC | 1,537,271 | $38,723,856 | 4.26% |
| Millrace Asset Group, Inc. | 72,595 | $1,829 | 2.13% |
| Divisadero Street Capital Management, LP | 175,000 | $4,408,250 | 1.93% |
| Perceptive Advisors | 2,442,250 | $61,520,278 | 1.82% |
| SECTORAL ASSET MANAGEMENT INC | 366,443 | $9,230,699 | 1.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,120,875 | $28,234,841 | 1.67% |
| EMERALD ADVISERS, LLC | 1,363,453 | $34,345,381 | 1.65% |
| FORMULA GROWTH LTD | 124,900 | $3,146,231 | 1.01% |
| Novo Holdings A/S | 540,000 | $13,602,600 | 0.90% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 755,379 | $19,027,997 | 0.78% |